Advanced search
Publication Cover
Clinical Lipidology Volume 6, 2011 - Issue 4
Submit an article Journal homepage
8,529
Views
31
CrossRef citations to date
0
Altmetric
Reviews

Pathophysiology of diabetic dyslipidemia:implications for atherogenesis and treatment

Mary SugdenUniversity of London, Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, Barts and London School of Medicine and Dentistry, Queen Mary, 4 Newark Street, Whitechapel, E1 2AT, London, UK, Tel.: +44 207 882 2355; Fax.: +44 207 882 2186, E-mail: [email protected]Correspondence[email protected]
&
Mark HolnessUniversity of London, Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, Barts and London School of Medicine and Dentistry, Queen Mary, 4 Newark Street, Whitechapel, E1 2AT, London, UK, Tel.: +44 207 882 2355; Fax.: +44 207 882 2186, E-mail: [email protected]
Pages 401-411 | Published online: 18 Jan 2017

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kassahun Haile & Abebe Timerga. (2020) Dyslipidemia and Its Associated Risk Factors Among Adult Type-2 Diabetic Patients at Jimma University Medical Center, Jimma, Southwest Ethiopia. Diabetes, Metabolic Syndrome and Obesity 13, pages 4589-4597.
Read now

Articles from other publishers (30)

Veronica F. Salau, Ochuko L. Erukainure, Kolawole O. Olofinsan, Vishal Bharuth, Omamuyovwi M. Ijomone & Md. Shahidul Islam. (2022) Ferulic acid improves glucose homeostasis by modulation of key diabetogenic activities and restoration of pancreatic architecture in diabetic rats. Fundamental & Clinical Pharmacology 37:2, pages 324-339.
Crossref
Minakshi M. Dhoru, Maitri P. Parikh, Krunal K. Detholia & Pathik J. Patel. (2023) DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN AND TENELIGLIPTIN IN THEIR SYNTHETIC MIXTURE. Indian Drugs 60:02, pages 60-69.
Crossref
Arvind Gupta & Rajeev Gupta. (2022) Current Understanding of Diabetic Dyslipidemia: A Review. Journal of the Indian Institute of Science 103:1, pages 287-307.
Crossref
Ahmed AlshawiHaider Ali Alnaji. (2022) TG/HDL, Non-HDL, and TyG index as predictive parameters for CVDs in uncontrolled diabetic patients better than LDL-C and LDL/HDL ratio. Research Journal of Pharmacy and Technology, pages 5490-5494.
Crossref
Daba Abdissa & Delessa Hirpa. (2022) Dyslipidemia and its associated factors among adult diabetes outpatients in West Shewa zone public hospitals, Ethiopia. BMC Cardiovascular Disorders 22:1.
Crossref
Boonsub Sakboonyarat, Jaturon Poovieng, Kanlaya Jongcherdchootrakul, Phutsapong Srisawat, Panadda Hatthachote, Mathirut Mungthin & Ram Rangsin. (2022) Prevalence of hypertriglyceridemia among Royal Thai Army personnel and its related cardiometabolic risk factors, from 2017 to 2021. BMC Public Health 22:1.
Crossref
Masahiko Iwamoto, Tetsuya Kubota, Yoshitaka Sakurai, Nobuhiro Wada, Seiji Shioda, Toshimasa Yamauchi, Takashi Kadowaki & Naoto Kubota. (2022) The sodium‐glucose co‐transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE‐deficient mice with streptozotocin‐induced diabetes. Pharmacology Research & Perspectives 10:4.
Crossref
Hagos Amare Gebreyesus, Girmatsion Fisseha Abreha, Sintayehu Degu Besherae, Merhawit Atsbha Abera, Abraha Hailu Weldegerima, Aregawi Haileslassie Gidey, Afework Mulugeta Bezabih, Tefera Belachew Lemma & Tsinuel Girma Nigatu. (2022) High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia. PLOS ONE 17:2, pages e0262610.
Crossref
Claude Pierre-Jerome. 2022. The Essentials of Charcot Neuroarthropathy. The Essentials of Charcot Neuroarthropathy 261 285 .
Theresa Berent, Kurt Derfler & Robert Berent. (2021) Hypertriglyzeridämie verstehenUnderstanding hypertriglyceridemia. Der Kardiologe 15:5, pages 509-518.
Crossref
Jana Blahova, Monika Martiniakova, Martina Babikova, Veronika Kovacova, Vladimira Mondockova & Radoslav Omelka. (2021) Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus. Pharmaceuticals 14:8, pages 806.
Crossref
Subashini C. Thambiah & Leslie Charles Lai. (2021) Diabetic dyslipidaemia. Practical Laboratory Medicine 26, pages e00248.
Crossref
Oelfah Patel, Christo J. F. Muller, Elizabeth Joubert, Bernd Rosenkranz, Johan Louw & Charles Awortwe. (2021) Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice. PLOS ONE 16:5, pages e0251069.
Crossref
Cosmin Mihai Vesa, Loredana Popa, Amorin Remus Popa, Marius Rus, Andreea Atena Zaha, Simona Bungau, Delia Mirela Tit, Raluca Anca Corb Aron & Dana Carmen Zaha. (2020) Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors. Diagnostics 10:5, pages 314.
Crossref
A. Macho-González, A. Garcimartín, M.E. López-Oliva, P. Celada, S. Bastida, J. Benedí & F.J. Sánchez-Muniz. (2020) Carob-fruit-extract-enriched meat modulates lipoprotein metabolism and insulin signaling in diabetic rats induced by high-saturated-fat diet. Journal of Functional Foods 64, pages 103600.
Crossref
Ifeanacho Mercy Onuekwuzu, Ikewuchi Catherine Chidinma & Ikewuchi Jude Chigozie. (2019) Anti-Diabetic Effect of a Flavonoid and Sitosterol - Rich Aqueous Extract of Pleurotus tuberregium Sclerotia in Alloxan-Induced Diabetic Rabbits . Endocrine, Metabolic & Immune Disorders - Drug Targets 19:8, pages 1148-1156.
Crossref
Beatrice Ohunene Bello-Ovosi, Joseph Ogirima Ovosi, Modupe Arinola Ogunsina, Sunday Asuke & Muhammed Sani Ibrahim. (2019) Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria. Pan African Medical Journal 34.
Crossref
Ochuko L. Erukainure, Olajumoke A. Oyebode, Omamuyovwi M. Ijomone, Chika I. Chukwuma, Neil A. Koorbanally & Md. Shahidul Islam. (2019) Raffia palm (Raphia hookeri G. Mann & H. Wendl) wine modulates glucose homeostasis by enhancing insulin secretion and inhibiting redox imbalance in a rat model of diabetes induced by high fructose diet and streptozotocin. Journal of Ethnopharmacology 237, pages 159-170.
Crossref
Z.S. Siti, A.M.I. Seoparjoo & H. Shahrul. (2019) Lipoproteins modulate growth and P-glycoprotein expression in drug-resistant HER2-overexpressed breast cancer cells. Heliyon 5:4, pages e01573.
Crossref
Kok-Lun Pang & Kok-Yong Chin. (2019) The Role of Tocotrienol in Protecting Against Metabolic Diseases. Molecules 24:5, pages 923.
Crossref
Adrián Macho-González, Alba Garcimartín, María López-Oliva, Baltasar Ruiz-Roso, Isabel Martín de la Torre, Sara Bastida, Juana Benedí & Francisco Sánchez-Muniz. (2019) Can Carob-Fruit-Extract-Enriched Meat Improve the Lipoprotein Profile, VLDL-Oxidation, and LDL Receptor Levels Induced by an Atherogenic Diet in STZ-NAD-Diabetic Rats?. Nutrients 11:2, pages 332.
Crossref
G.B. John Mancini, Robert A. Hegele & Lawrence A. Leiter. (2018) Dyslipidemia. Canadian Journal of Diabetes 42, pages S178-S185.
Crossref
Ngozi D. Mbue, John E. Mbue & Jane A. Anderson. (2017) Management of Lipids in Patients with Diabetes. Nursing Clinics of North America 52:4, pages 605-619.
Crossref
Thomas Forst & Christoph KaptizaArmin Steinmetz. 2015. Clinical Advances in Diabetes Mellitus. Clinical Advances in Diabetes Mellitus 170 188 .
Michelle L. Frank & Annie M. Gerhardt. (2015) Treating dyslipidemia in patients with type 2 diabetes mellitus. The Nurse Practitioner 40:8, pages 18-22.
Crossref
H. Drexel, S. Jacob, K. G. Parhofer, C. Säly, H. Schatz & A. Vonbank. 2014. Diabetologie kompakt. Diabetologie kompakt 217 237 .
G. B. John Mancini, Robert A. Hegele & Lawrence A. Leiter. (2013) Dyslipidémie. Canadian Journal of Diabetes 37, pages S484-S491.
Crossref
K.G. Parhofer. (2013) Update FettstoffwechselstörungenUpdate dyslipidemia. Der Internist 54:9, pages 1089-1103.
Crossref
G.B. John Mancini, Robert A. Hegele & Lawrence A. Leiter. (2013) Dyslipidemia. Canadian Journal of Diabetes 37, pages S110-S116.
Crossref
A. Wirth, H. Hauner, M. Roden, K. Parhofer, M. May, St. Engeli, J. Jordan, R. Schulz, K.T.M. Schneider, V.A. Grote, B. Teucher & R. Kaaks. 2013. Adipositas. Adipositas 173 257 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.